Bladder cancer is the fifth most common cancer in the United States and, until recently, those with the advanced form of the disease might have received the same type of treatment as they would have in the 1980s. Now, a new medicine has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of people with a type of bladder cancer called locally advanced or metastatic urothelial carcinoma (mUC). The drug may be used: when your bladder cancer has spread or cannot be removed by surgery (advanced urothelial carcinoma), and you have tried chemotherapy that contains platinum, and it did not work or is no longer working.4 Urothelial carcinoma accounts for 90 percent of all bladder cancers and can also be found in the renal pelvis, ureter and urethra
Posted at 9:06 AM, May 30, 2016
and last updated 2016-05-30 09:06:00-04
Copyright 2015 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.